Vimarsana
Biggest News Aggregation in the World

Marksans Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Marksans Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Marksans Pharma Today - Breaking & Trending Today

Marksans Pharma Q4 Results Live : profit falls by 4.44% YOY - Vimarsana News

Marksans Pharma Q4 Results Live : profit falls by 4.44% YOY

Marksans Pharma Q4 Results Live : Revenue increased by 15.23% YoY & profit decreased by 4.44% YoY

Q4 results today: Apollo Hospitals among 895 companies to announce earnings on Thursday - Vimarsana News

Q4 results today: Apollo Hospitals among 895 companies to announce earnings on Thursday

Fourth quarter earnings season is wrapping up with 895 companies reporting results on Thursday. Investors keenly await Apollo Hospitals' results, expecting robust growth driven by improved ARPOB and HealthCo operations. Analysts predict up to a 68% YoY increase in net profit, with sales expected to rise by 13%.

INDIA STOCKS-Indian shares fall for fifth session on weak global cues, election uncertainties - Vimarsana News

INDIA STOCKS-Indian shares fall for fifth session on weak global cues, election uncertainties

Indian shares fell for a fifth straight session on Thursday, pressured by weakness in global peers, while some investors trimmed positions ahead of federal election results. The NSE...

Marksans Pharma gains on UK health regulator nod to market new oral solution - Vimarsana News

Marksans Pharma gains on UK health regulator nod to market new oral solution

Marksans Pharma received the UK health regulator's nod to market its new oral solution for epilepsy patints.

investment strategy: Kenneth Andrade on why he is avoiding banks & financials; betting on power, pharma stocks - Vimarsana News

investment strategy: Kenneth Andrade on why he is avoiding banks & financials; betting on power, pharma stocks

Kenneth Andrade anticipates significant growth in the power market, emphasizing massive investments in energy capex equivalent to India's GDP over the next 15 years. He discusses the impact on various sectors and the rationale behind his pharma holdings, focusing on profitability potential. Andrade says he is avoiding banks because he chooses to be on the asset side and not on the liability side.